Related Experiment Video
Updated: Jul 2, 2025

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
Assessing peptic ulcer risk with the HAMPROW score in the general Chinese population
Binli Wang1, Weitao Yu2,3, Zheyu Zhang4
1Department of Neurology, Huzhou Nanxun People's Hospital, Zhejiang Provincial People's Hospital Nanxun District, Huzhou, China.
A new HAMPROW score effectively identifies individuals at high risk for peptic ulcers (PUs) in China. This tool aids in preventing gastrointestinal bleeding before antiplatelet therapy.
Area of Science:
- Gastroenterology
- Internal Medicine
- Preventive Medicine
Background:
- Peptic ulcers (PUs) pose a risk for gastrointestinal bleeding, particularly during antiplatelet therapy.
- Timely identification of high-risk individuals is crucial for effective prevention strategies.
- A validated risk assessment model is needed for the general Chinese population.
Purpose of the Study:
- To identify independent risk factors for peptic ulcers in the Chinese population.
- To develop and validate a predictive model for peptic ulcer risk.
- To facilitate early detection and prevention of gastrointestinal bleeding.
Main Methods:
- Prospective study of 902 patients undergoing gastroscopy (April 2019-May 2022).
- LASSO-derived logistic regression analysis to identify risk factors and develop the HAMPROW score.
- Temporal validation of the developed risk score.
Main Results:
- Seven independent risk factors identified: male sex, white blood cell count, red blood cell count, globulin level, albumin level, pepsinogen I level, and positive Helicobacter pylori antibody.
- The HAMPROW score demonstrated strong predictive ability with AUCs of 0.854 (development) and 0.833 (validation).
- The score effectively predicts peptic ulcer risk in the Chinese population.
Conclusions:
- The HAMPROW score is a reliable tool for screening peptic ulcer risk in the general Chinese population.
- This model supports personalized early detection of high-risk individuals.
- Early risk assessment can help prevent gastrointestinal bleeding associated with antiplatelet therapy.
More Related Videos
03:47Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
Published on: November 1, 2024
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease